Results 251 to 260 of about 90,511 (304)

Palliative thoracic radiotherapy for lung cancer

Expert Review of Anticancer Therapy, 2010
Despite an increasing use of chemotherapy in the palliative setting for lung cancer, the role of palliative thoracic radiotherapy should not be disregarded. It offers quick and efficient palliation, with improvement observed in approximately two-thirds of treated patients.
Lucyna, Kepka, Marta, Olszyna-Serementa
openaire   +2 more sources

Unrecognized thoracic radiotherapy toxicity: A review of literature

Cancer/Radiothérapie, 2022
Radiotherapy remains an important treatment modality for patients with chest malignancies; this is particularly true in patients with breast cancer and Hodgkin lymphoma as well as lung, esophageal, and other mediastinal tumors. More than half of patients with these conditions receive radiotherapy at some point.
A. Latrèche, V. Bourbonne, F. Lucia
openaire   +2 more sources

Future directions in palliative thoracic radiotherapy

Current Opinion in Supportive & Palliative Care, 2012
Recent systematic review, practice guidelines, and consensus statements have summarized the known clinical trial information with regards to the appropriate use of external-beam radiation, brachytherapy, and concurrent chemotherapy (with external-beam radiotherapy) in the palliation of chest symptoms with thoracic radiotherapy.
George, Rodrigues, Benjamin, Movsas
openaire   +2 more sources

Radiotherapy for thoracic tumours

2019
Chapter 6 discusses radiotherapy for thoracic tumours and includes discussion on lung cancer. The chapter covers assessment of patients with lung cancer for radical radiotherapy, patient positioning for radical radiotherapy for lung cancer, tumour motion, target delineation, organs at risk, implementation on the treatment machine, treatment ...
Kevin Franks, Fiona McDonald, Gerard G Hanna   +2 more
openaire   +1 more source

Radiotherapy for thoracic tumours

2013
Chapter 5 discusses two main subtypes of lung cancer; small cell (SCLC) and non-small cell (NSCLC). However, the management is becoming increasingly similar so the general principles of lung cancer radiotherapy will be discussed first, followed by the specific features of management of the two pathological entities.
Sara C Erridge, Elizabeth Toy, Sorcha Campbell   +2 more
openaire   +1 more source

Radiotherapy for Thoracic Esophageal Squamous Cell Carcinoma

2020
Esophageal squamous cell carcinoma (ESCC) is an aggressive disease. Many patients have locally advanced disease or already have distant metastasis at presentation. Radiotherapy plays an important role in the treatment of esophageal squamous cell carcinoma.
Wendy W L, Chan, Ka On, Lam, Dora L W, Kwong   +2 more
openaire   +2 more sources

Pediatric radiotherapy for thoracic and abdominal targets

Radiotherapy and oncology, 2022
For radiotherapy of thoracic and abdominal tumors safety margins are applied to address geometrical uncertainties caused by e.g. set-up errors, organ motion and delineation variability. For pediatric patients no standardized margins are defined. Moreover, studies on these geometrical uncertainties are relatively scarce.
Meijer, Karin M., van Dijk, Irma W. E. M., Huijskens, Sophie C., Daams, Joost G., Balgobind, Brian V., Bel, Arjan   +5 more
openaire   +1 more source

Thoracic radiotherapy for renal cell carcinoma metastases.

Journal of Clinical Oncology, 2020
409 Background: For patients with metastatic renal cell carcinoma (RCC), metastasis-directed local therapies can delay progression and need to initiate/switch systemic therapy. We examined our experience treating lung or mediastinal metastases from RCC with radiotherapy (RT).
Glenn Stewart, William Breen, Brad J. Stish, Sean Sunghun Park, Kenneth R. Olivier, Brian Addis Costello   +5 more
openaire   +1 more source

Fractionation and dose in thoracic radiotherapy

Lung Cancer, 1994
The results of radiotherapy in non-small cell lung cancer confined to the mediastinum are disappointing. Conventional radiotherapy giving 60 Gy in 6 weeks gives primary tumour control of up to 23% with a 1 and 2-year survival of the order of 35% and 12%, respectively.
openaire   +2 more sources

Reevaluation of postoperative radiotherapy for thoracic esophageal carcinoma

International Journal of Radiation Oncology*Biology*Physics, 1997
To reevaluate postoperative radiotherapy for thoracic esophageal carcinoma.Reviewed were the outcome of 89 patients who underwent esophagectomy with systematic dissection of regional lymph nodes between 1988 and 1993. Of the 89 patients, 19 underwent no adjuvant treatment, 22 underwent adjuvant chemotherapy alone, and 48 underwent postoperative ...
M, Yamamoto, T, Yamashita, T, Matsubara, T, Kitahara, K, Sekiguchi, M, Furukawa, A, Uki, M, Kobayashi, E, Tanaka, M, Ueda, T, Nakajima   +10 more
openaire   +2 more sources